Joana Vindeirinho, PhD,  —

The Cystic Fibrosis Foundation is investing up to $2 million in Nanite to develop new non-viral methods of delivering gene therapies into the lungs of people with cystic fibrosis (CF). “We’re thrilled to announce this investment from the Cystic Fibrosis Foundation, which we will use to explore…

Type 2 diabetes in a 49-year-old woman with cystic fibrosis (CF) went into remission after bariatric surgery, given to help her lose weight after obesity was seen as the likely cause of her blood-sugar levels. She had a mild form of CF, stable pulmonary function and pancreatic sufficiency, supporting…

CFTR gene mutations — the cause of cystic fibrosis (CF) — significantly reduce the cell entry and replication of SARS-CoV-2, the virus responsible for COVID-19, a new study reports. This protective effect was due to the link between the CFTR protein channel and angiotensin-converting enzyme 2 (ACE-2), a protein…

People with cystic fibrosis (CF) and advanced lung disease who have bacterial communities dominated by just one type of bacteria have a higher risk of lung transplant or death than those with more diverse communities, a study reports. The risk of needing a lung transplant or death was increased…